中国女性血清C反应蛋白水平与消化系统肿瘤风险关联的前瞻性随访研究
截至2014年12月31日共观察到100例新发肿瘤,hsCRP>3 mg/L组胰肝胆癌风险较<1 mg/L组显著升高(HR=2.70)。
要点
- 基线hsCRP升高与中国女性消化系统肿瘤总体风险增加相关。
- hsCRP>3 mg/L组8年累积发病率787/10万,高于<1 mg/L组405/10万。
- hsCRP>3 mg/L组胰肝胆癌风险较<1 mg/L组升高(HR=2.70)。
核心结论
- 基线hsCRP水平升高可能与中国女性部分消化系统肿瘤风险增加相关。
研究设计与样本
- 基线检测所有受试者血清hsCRP并收集人口学及危险因素数据,采用多因素Cox比例风险回归模型计算风险比(HR)及95%置信区间(95%CI),调整年龄、婚姻状况、吸烟、饮酒、体质指数(BMI)、糖尿病和体力活动。
主要发现
- 截至2014年12月31日共观察100例新发肿瘤,包括结直肠癌47例、胃癌17例,胰腺癌、肝癌和胆囊癌合计29例。
- 按hsCRP水平分三组(<1 mg/L、1-3 mg/L、>3 mg/L),8年消化系统肿瘤累积发病率分别为405/10万、520/10万和787/10万(Log rank检验χ2=8.37,P=0.015)。
- 与hsCRP<1 mg/L者相比,hsCRP>3 mg/L者胰腺癌、肝癌和胆囊癌风险显著升高(HR=2.70,95%CI=1.06-6.91;Ptrend=0.036)。
临床怎么用
- 原文结论指出基线hsCRP升高可能与部分消化系统肿瘤风险增加相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: It has been reported by some prospective studies that C-reactive protein (CRP) is associated with cancer risk. However, the correlation between CRP and digestive system cancers has not been evaluated in Chinese females. We conducted a large population-based cohort study to investigate whether elevated level of CRP in serum is associated with an increased risk of digestive system cancers in Chinese women. Methods: From the Chinese Kailuan Female Cohort, 19, 437 women were enrolled in this study in July 2006, and all of the subjects were followed up through 2014. At the baseline investigation, the serum levels of high-sensitivity CRP (hsCRP) were tested for all subjects, and demographic information and risk factor data were collected. Multivariable Cox proportional hazards regression model was used to calculate the hazard ratios (HR) and 95% confidence intervals (95% CI) for the baseline levels of hsCRP after adjusting for age, marital status, smoking, drinking, body mass index (BMI), diabetes and physical activity, and risk of digestive system tumors (including colorectal cancer, stomach cancer, pancreas cancer, liver and gallbladder cancer, and other cancers). Results: By Dec 31, 2014, a total of 100 incident cancer cases were observed, including 47 colorectal cancers, 17 stomach cancers, and altogether 29 pancreas, liver and gallbladder cancers. All the subjects investigated were divided into three groups according to the level of hsCRP (<1 mg/L, 1-3 mg/L and >3 mg/L). The 8-year cumulative incidence of digestive system cancers were 405/100 000, 520/100 000 and 787/100 000 in these 3 groups, respectively (Log rank test χ2 = 8.37, P=0.015). Compared to those with lower hsCRP levels (<1 mg/L), the women with higher hsCRP (>3 mg/L) had a significantly increased risk of pancreas, liver and gallbladder cancers (HR = 2.70, 95% CI = 1.06-6.91; Ptrend = 0.036). Conclusions: Elevated levels of hsCRP at baseline may be associated with increased risk of certain digestive system cancers.
引用
- Wang G, Cao LY, Chen SH, et al. [A prospective follow-up study on the association between serum level of C-reactive protein and risk of digestive system cancers in Chinese women]. Zhonghua Zhong Liu Za Zhi. 2016. PMID: 27998450. doi:10.3760/cma.j.issn.0253-3766.2016.11.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。